Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade

Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis, and Prognostication

#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer

Grappling with Coronavirus (SARS-CoV-2)

IASLC 2020 World Conference on Lung Cancer Postponed

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia

TRK Inhibition in TRK Fusion–Positive Lung Cancers

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr. Edgardo S. Santos Castillero

CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in NSCLC

Smoking Ban in Austria Passed After Years of Political Wrangling